At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Venture Partner operating in the Venture Capital space. If you think a Venture Partner is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
William Guillouard
Venture Partner of FJ Labs
Follow William Guillouard:
About FJ Labs: FJ Labs is a stage-agnostic investment firm that focuses on marketplaces and consumer facing startups.
Cyan Banister
Venture Partner, The Frontier of Long Journey Ventures
Cyan Banister is a partner at Founders Fund, where she invests across sectors and stages with a particular interest in augmented reality, fertility, heavily regulated industries and businesses that help people with basic skills find meaningful work. Prior to joining Founders Fund, Cyan was an active angel investor with a portfolio including Uber, Thumbtack, SpaceX, Postmates, EShares, Affirm and Niantic, creator of Pokémon GO. A self-taught engineer and entrepreneur, Cyan has held a number of technical leadership positions throughout her career. As an early employee at IronPort, which was acquired by Cisco, Cyan oversaw support infrastructure and performance for a global customer base. She has a passion for the arts and is a voracious film, documentary and media consumer.
Follow Cyan Banister:
About Long Journey Ventures, Signal Media Project, Thankroll: Long Journey Ventures is an early stage venture capital firm focused on early and new investments.
Pascal Levy-Garboua
Venture Partner of Long Journey Ventures
Pascal Levy-Garboua is an angel investor, founder, and operator. He is currently VP. Business Development at Checkr, where he joined as their first executive and Employee #9. Previously, he was CEO/Cofounder at SixDoors, Cofounder at VirtuOz (acquired by Nuance Communications) and VP Product at IQ Engines (Acquired by Yahoo). He started his career at eBay in France. Pascal invested in 85+ Companies including Checkr, Wag, Womply, Origin, RealtyShares, and Caviar (Acquired by Square).
Follow Pascal Levy-Garboua:
About Long Journey Ventures: Long Journey Ventures is an early stage venture capital firm focused on early and new investments.
Keith Lenden
Venture Partner of ARCH Venture Partners
Mr. Lenden is a senior advisor to Autobahn Therapeutics. He is also a co-founder In addition to his role at Autobahn, Mr. Lenden is a venture partner at ARCH Venture Partners. Mr.Lenden is a seasoned entrepreneur and leader in the biotechnology and pharmaceutical industries with a proven track record in company formation, executive and project leadership, corporate development and product and market strategy. Mr. Lenden was a co-founder of Receptos, Inc., a multiple sclerosis biology and GPCR drug discovery company acquired by Celgene (now BMS), Abide Therapeutics, Inc., a cannabinoid biology and serine hydrolase drug discovery company acquired by H. Lundbeck A/S, and Boundless Bio, Inc., an ecDNA cancer biology and drug discovery company. Mr. Lenden has served in a wide range of executive and product leadership roles for both public and private biopharmaceutical companies over the years, including Esperion Therapeutics, Inc., Maxygen, Inc., Acologix, Inc. and Genteric, Inc. Mr. Lenden started his career in biotechnology as a consultant at LEK Consulting. Mr. Lenden holds an MBA from the Haas School of Business at the University of California, Berkeley where he was selected as a Price Institute for Entrepreneurial Studies Venture Capital Fellow. Mr. Lenden also holds and A.B. and B.E. from the Thayer School of Engineering at Dartmouth College. Mr. Lenden is a Kauffman Fellow where he received the Jeff Timmons Leadership Award.
Follow Keith Lenden:
About ARCH Venture Partners, Autobahn Therapeutics, Boundless Bio: ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Scott Minick
Venture Partner of ARCH Venture Partners
Follow Scott Minick:
About Aira, ARCH Venture Partners: ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Thomas Daniel
Venture Partner of ARCH Venture Partners
Thomas O. Daniel was President, Global Research and Early Development at Celgene Corporation over the last decade, as the company emerged as a leader in defining new mechanisms for drug action, established industry leading collaborative networks, and advanced and commercialized innovative medicines in oncology and inflammatory diseases. He previously served as Chief Scientific Officer and Director of AmbRx, as Vice President of Research at Amgen, and as Senior Vice President of Discovery Research at Immunex Corporation. Tom is currently a director at Juno Therapeutics and Zafgen, Inc. He is founding director of Catalysis Advisors and is a venture partner at Arch Venture Partners. He serves on the Biomedical Science Advisory Board of Vanderbilt University Medical Center, is a member of the Therapeutic Advisory Board of aTyr Pharma and is a senior advisor to BlackThorn Therapeutics. A nephrologist and former academic investigator, Tom was previously C.M. Hakim Professor of Medicine and Cell Biology at Vanderbilt. He earned his medical degree from the University of Texas, Southwestern, trained in molecular genetics at UTSW, and completed a medical residency at Massachusetts General Hospital.
Follow Thomas Daniel:
About ARCH Venture Partners: ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Tom Brennan
Venture Partner of ARCH Venture Partners
Tom Brennan joined ARCH as a Venture Partner. He has special focus on ARCH activities at Sandia National Laboratories and Los Alamos National Laboratory. During his first year with ARCH, he served as an Entrepreneur in Residence (EIR) at Sandia National Laboratories (SNL), a position supported by a Department of Energy grant awarded to ARCH early in 2008. Mr. Brennan began his career as a member of the technical staff at AT&T Bell Labs, then joined Sandia in 1986 where he became a senior member of the technical staff focused on the material growth of III-V semiconductor materials and devices. Mr. Brennan’s work included the growth of some of the first ‘vertical cavity surface-emitting laser’ (VCSEL) material at Sandia and in the U.S., and the development of new and unique VCSEL manufacturing techniques. In 1994, Mr. Brennan and a colleague from SNL collaborated with ARCH Managing Directors, Clint Bybee and Keith Crandell, to license the VCSEL technology from SNL and co-founded MicroOptical Devices. Mr. Brennan was Co-President of MODE through December 1997 when EMCORE Corp. acquired MicroOptical Devices and established a new business unit called EMCORE Photovoltaics, which Mr. Brennan started-up and led as its General Manager. In 2001, Mr. Brennan was named President and CEO of Zia Laser, a spin-out from the Center for High Technology Materials at the University of New Mexico, which developed quantum dot laser diodes. He also served as Chairman of Medical Lighting Solutions, which uses solid state lighting to treat disease. Mr. Brennan holds an A.S. in Chemistry from the Florida Institute of Technology, a B.S. in Biochemistry from Monmouth College, and an M.S. in Material Science from Steven’s Institute of Technology. He has published more than 120 articles and holds twelve patents issued and pending.
Follow Tom Brennan:
About ARCH Venture Partners: ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Alex Estevez
Venture Partner of Accel
Alex Estevez is the Chief Financial Officer at Atlassian.
Follow Alex Estevez:
About Accel: Accel is an early and growth-stage venture capital firm that helps a global community of entrepreneurs.
Eric Wolford
Venture Partner of Accel
Eric Wolford Is The Venture Partner at Accel Partners.
Follow Eric Wolford:
About Accel: Accel is an early and growth-stage venture capital firm that helps a global community of entrepreneurs.
Jim Flach
Venture Partner of Accel
Jim Flach has held a wide range of positions in the communications and software industries in which he has worked for over thirty years. A partner with Accel for ten years, he was formerly Chairman of Agile Networks (Lucent), Netlink (Cabletron), Sentient Networks (Cisco), Teleos Communications (Madge Networks), and Vivo Software. Jim has served as CEO of Terraspring, Teleos, Bandwidth9, Hybrid Networks, Redback Networks, and Sentient Networks. He also serves on the board of Bandwidth9, CenterBeam, GoDigital Telecommunications, Hybrid Networks, P-Cube, Primarion, Vertical Networks, and Terraspring. Previously, Jim was Vice President of Intel where he was General Manager of the Personal Computer Enhancement Division. He came to Intel in 1989 when Intel acquired his communications company, Jupiter Technology, where he had been CEO since 1986. Prior to joining Intel, Jim held numerous business and technical positions during a seventeen-year career at Xerox Corporation, including Vice President of Systems Engineering, and Vice President and General Manager of the Network Systems Business Unit, and was responsible for the worldwide P&L of the Xerox Network business. Jim holds a B.S. degree in Physics from Rensselaer Polytechnic Institute and an M.S. degree in Applied Mathematics from the Rochester Institute of Technology.
Follow Jim Flach:
About Accel: Accel is an early and growth-stage venture capital firm that helps a global community of entrepreneurs.
Jonathan Weiner
Venture Partner of Oak HC/FT
Follow Jonathan Weiner:
About Growth – Cannabis Conference, HLTH, Oak HC/FT: Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.
Michael Heller
Venture Partner of Oak HC/FT
Michael identifies new investment opportunities and assists portfolio companies with strategic initiatives. Michael is an accomplished operator and entrepreneur with 30 years of experience within the payments and banking industries. He was cofounder and president of Argus Information & Advisory Services, an information services firm that serves the banking industry. At Argus, Michael managed key partners, including credit bureaus and media measurement organizations. He provided strategic advisory services to a majority of the largest US banks and UK financial institutions. Michael graduated with a Bachelor of Arts from Wesleyan University and a Master of Business Administration from the Kellogg Graduate School of Management at Northwestern University.
Follow Michael Heller:
About MissionOG, Oak HC/FT: Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.
Zeke Emanuel
Venture Partner of Oak HC/FT
Follow Zeke Emanuel:
About Oak HC/FT: Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.
Nick Adams
Venture Partner of AME Cloud Ventures
Nick manages AME Cloud’s early stage investments. Prior to AME Cloud, Nick spent five years in China and India, where he lead business development for Cloud Valley and founded a web travel company and a software-services company. Nick earned his Masters in Engineering from Imperial College.
Follow Nick Adams:
About AME Cloud Ventures, Cloud Valley: AME Cloud Ventures invests in seed to later-stage tech companies that build infrastructure and value chains around data.
Umaimah Mendhro
Venture Partner of HOF Capital
Umaimah Mendhro is the Founder and CEO of HOF’s portfolio company VIDA, a global platform that connects creatives and producers from around the world to produce and sell original, quality products at scale. Prior to founding VIDA, Umaimah was a Director at West, where she led product strategy for promising pre-IPO tech startups. Previously, Umaimah was Director of Product in Microsoft’s Startup Business Group where she led the division’s efforts around incubation on Xbox Kinect. She has launched new consumer businesses and led growth from zero to millions of users. She holds 13 Patent Awards in media and entertainment.Umaimah is also the Founder of thedreamfly.org, a global initiative connecting communities in conflict around common causes with presence across four countries touching over 5,000 lives. Umaimah has an MBA from Harvard Business School, where she was a Baker Scholar, and a B.Sc. from Cornell University in Human Development with coursework in Computer Science.
Follow Umaimah Mendhro:
About HOF Capital, VIDA: HOF Capital is a global multistage VC firm with $1 billion in AUM that partners with ambitious entrepreneurs from idea to IPO.
John Thompson
Venture Partner of Lightspeed Venture Partners
John Thompson currently works as the Venture Partner for Lightspeed Venture Partners. He previously worked at Riverwood Capital Management as the Executive Advisor.
Follow John Thompson:
About Lightspeed Venture Partners: Lightspeed Venture Partners is a venture capital firm that engages in consumer, enterprise, technology, and cleantech markets.
Adam Goldberg
Venture Partner of Lightspeed Venture Partners
Adam Goldberg is the Co-Founder of Standard Crypto. Adam focuses primarily on investments in enterprise infrastructure, big data/analytics, datacenter technologies, IIoT, frontier technologies, and artificial intelligence. At age 13, Adam enrolled as a full-time student at UC Berkeley, where he studied pure and applied mathematics and conducted research in number theory and machine learning. Prior to Lightspeed, he was an early product manager at Rubrik (a Lightspeed portfolio company) where he launched a product line. Previously, he has worked as an engineer at Dropbox and Palantir, as a mathematician at the Department of Defense, and as a researcher at Stanford InfoLab, Lawrence Berkeley National Laboratory, and the University of Wisconsin-Madison. He also was a technical consultant for HBO’s Silicon Valley. Adam graduated from Stanford with a B.S. in Computer Science with a concentration in systems. At Stanford, he was a founding partner of the Dorm Room Fund in conjunction with First Round Capital.
Follow Adam Goldberg:
About Lightspeed Venture Partners, Standard Crypto: Lightspeed Venture Partners is a venture capital firm that engages in consumer, enterprise, technology, and cleantech markets.
Jonathan MacQuitty
Venture Partner of Lightspeed Venture Partners
Jonathan MacQuitty is the Chief Executive Officer at D2G Oncology. He has more than 15 years of operational experience in life science companies and over 14 years of venture capital experience. His directorships have included Adiana, Dicerna, Entelos, Guava, Gynesonics, Labcyte, ParAllele BioScience, Personalis, SFJ Pharmaceuticals and Sunesis. He joined Abingworth in 1999 as President and Director of the company’s US subsidiary, Abingworth Management Inc, and is based at the firm’s offices in Menlo Park, California. Before joining Abingworth he was an adviser to a Japanese venture capital firm. Between 1988 and 1997 he was CEO of GenPharm International, a biotech company in which Abingworth invested. Before this he held business development positions at Genencor and Genentech. He has served on the Board of the Biotechnology Industry Organization. Jonathan has an MA in Chemistry from Oxford University, a PhD in Chemistry from the University of Sussex and an MBA from Stanford University. Jonathan is responsible for Abingworth’s Menlo Park office and focuses on West Coast deals.
Follow Jonathan MacQuitty:
About Adiana, Guava, Labcyte, Lightspeed Venture Partners: Lightspeed Venture Partners is a venture capital firm that engages in consumer, enterprise, technology, and cleantech markets.
Bipul Sinha
Venture Partner of Lightspeed Venture Partners
Bipul Sinha is a Partner at Lightspeed and focuses primarily on Internet, mobile and software sectors, with a particular interest in social utilities/apps and cloud services/infrastructure. Bipul’s current investments include Nutanix, Bromium, Pulse News, MyLikes, and Peel. He was also an investor in LiveProfile. Previously, Bipul worked at Blumberg Capital where he led investments in digital media, Internet and datacenter software infrastructure sectors. His selected investments include DoubleVerify, Nutanix, Hootsuite and CarWoo. Prior to venture capital, Bipul was with Bank of America Technology Investment Banking Group where he worked on M&A and equity financing transactions. Prior to banking, Bipul was Director of database and middleware products with Oracle Corporation. Bipul also held sales and engineering positions at American Megatrends and IBM. Bipul received his B.Tech. (Honors) in Electrical Engineering from Indian Institute of Technology, Kharagpur and holds an MBA from The Wharton School where he was a Palmer Scholar. Bipul also holds several patents in distributed computing.
Follow Bipul Sinha:
About Bromium, Confluera, Lightspeed Venture Partners, Rubrik: Lightspeed Venture Partners is a venture capital firm that engages in consumer, enterprise, technology, and cleantech markets.
Andy Sack
Venture Partner of Founders’ Co-op
Andy Sack has over 15 years experience running and investing in high tech businesses, most recently as co-founder and CEO of Judy’s Book, a local search social network. Prior to founding Judy’s Book in 2004, Andy co-founded three successful Internet technology companies: Kefta (acquired in 2007 by Axciom), a leading provider of real time customer interaction solutions; Abuzz, (acquired by New York Times Digital in 1999), an enterprises knowledge management solution named number one in the Internet software category by Red Herring Magazine and the top company to work for by Boston Magazine; and Firefly Network, an Internet company that pioneered internet personalization technologies (acquired by Microsoft). Andy also spent time as an entrepreneur in residence for SOFTBANK Venture Capital (now Mobius VC) where he founded and served on the board of three companies: BodyShop Digital, Quova, and Kefta. Andy currently serves on the board of and advises a number of companies including: zango, Cooler Planet, and Orange Line Media. Andy was also a founder and board member of Students for Responsible Business, and is a regular lecturer at the University of Washington Business School. Andy received his undergraduate degree from Brown University in 1990, and his MBA from the Sloan School of Management at MIT. Andy lives in Laurelhurst with his wife and two children.
Follow Andy Sack:
About BigDoor, Founders’ Co-op: Founders’ Co-op is a seed-stage investment firm that invests in technology companies.
Rudy Gadre
Venture Partner of Founders’ Co-op
Rudy Gadre is Partner at Founder’s Co-op. Rudy Gadre is an active angel Investor and is also an Advisor to startups. Rudy Gadre served as Vice President and General Counsel of Facebook, where Rudy Gadre was responsible for all legal matters since January 2006. In 1999, he joined Amazon and served as its Vice President and Associate General Counsel for Business Development, intellectual property, and new technologies. He was the Principal Legal Negotiator for Amazon’s most significant strategic alliances and joint ventures, where Rudy Gadre oversaw the development and licensing of patents and other intellectual property, and was responsible for all legal aspects of Amazon’s new technology initiatives. From September 1994 to February 1999, Rudy Gadre worked at Perkins Coie LLP, as an Associate in the technology business group. At Perkins, he represented clients ranging from startups to Fortune 100 companies in a diverse array of matters, including joint ventures, development, protection and licensing of intellectual property, and mergers and acquisitions. Rudy Gadre served as Vice President of Business Operations at Evri, Inc, from September 2008 to July 2010. He serves as a Member of Strategic Advisory Board at Syntonic Limited. He served as a Director of Jobaline.com Inc. He served as an Independent Director of The W Fund. He is a passionate supporter of the Seattle technology ecosystem. He was recognized by Washington Law and Politics magazine as a “Super Lawyer” in 2003 and 2004. Rudy Gadre holds a Bachelor of Arts degree in Economics from Franklin and Marshall College and graduated from the University of Washington School of Law.
Follow Rudy Gadre:
About Founders’ Co-op: Founders’ Co-op is a seed-stage investment firm that invests in technology companies.
Rob May
Venture Partner of PJC
Rob May is a General Partner at PJC with expertise in the areas of AI, hardware, B2B, and SaaS. Prior to joining PJC, Rob was the co-founder and CEO at Talla, an AI and automation platform, transforming the way businesses deliver customer support. He was also the co-founder and CEO of Backupify, the world’s first cloud to cloud backup provider which was acquired for over $100m. As an angel investor, he made over 70 early-stage AI investments. Rob writes the world’s most popular newsletter on Artificial Intelligence – InsideAI.
Follow Rob May:
About BotChain, Half Court VC, PJC, Talla: PJC is an early-stage venture capital firm with a focus on enterprise, consumer, and artificial intelligence.
Ben Robbins
Venture Partner of GV
Ben is a dual degree student at Harvard Medical School and Harvard Business School. He co-founded a company to monitor drug adherence at a community health center in Boston and a non-profit to operate a school for AIDS orphans in Tanzania. Ben received his Bachelor of Arts with honors from Dartmouth College and has been recognized multiple times for his social impact work including the Harvard Medical School Dean’s community service award, Harvard Medical School Agents of Change seed grant, Harvard Medical School Master Scholar scholarship, and Harvard Business School Social Enterprise fellowship.
Follow Ben Robbins:
About CareBridge, Cerevance, GV, Headway: GV provides venture capital funding to bold new companies.
Scott Davis
Venture Partner of GV
Scott Davis holds degrees in physics, mechanical and biomedical engineering, and brings broad technical expertise to the team as well as hands-on startup experience. Scott is a professor of engineering at Dartmouth College developing new optically-based cancer imaging techniques and contributes to the Google Ventures team on a part-time basis. Prior to his doctoral work in medical imaging, he was a key contributor to the success of Burlee.com, a leading Web hosting company acquired by Interland, Inc., now Web.com. Scott received a B.A. with honors in physics from Middlebury College, an M.S. in mechanical and aerospace engineering from the University of Virginia, and a Ph.D. in biomedical engineering from Dartmouth College.
Follow Scott Davis:
About GV: GV provides venture capital funding to bold new companies.
Brian Byun
Venture Partner of Khosla Ventures
Brian Byun is a venture partner at Khosla Ventures focused on B2B software including developer, data, security and cloud infrastructure. Prior to joining Khosla Ventures, Brian served as a VMware executive leading products, marketing and partnership functions as it scaled over 50X in employees and revenues from 2003 thru 2013. During this time he led the diversification of VMware from a single server and workstation product to an enterprise portfolio of datacenter, availability, management, desktop suites; built out the software, technology and OEM ecosystem; led corporate strategy and M&A including the developer platform basis for Pivotal Labs; and led portfolio of new product initiatives that form many of VMware’s post-datacenter businesses such as vCloud Network, CloudFoundry, enterprise mobility and cloud workspace. Previously Brian held software engineering, consulting, product management leadership roles in a range of domains (security, e-commerce, consumer web, distributed operating systems, servers and databases) at startups and industry incumbents: Rhapsody Networks (BRCD), AOL, Netscape and HP. Brian holds a SB in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology.
Follow Brian Byun:
About Khosla Ventures: Khosla Ventures is a venture capital firm that focuses on environmentally friendly tech, internet, computing, mobile, and silicon tech.
Adam Margolin
Venture Partner of Khosla Ventures
Adam Margolin is a Venture Partner at Khosla Ventures.
Follow Adam Margolin:
About Khosla Ventures, NextVivo: Khosla Ventures is a venture capital firm that focuses on environmentally friendly tech, internet, computing, mobile, and silicon tech.
Sagi Paz
Venture Partner of Entrée Capital
Follow Sagi Paz:
About Entrée Capital: Entrée Capital is a venture capital firm that funds multi-stage startups and companies all over the world.
Sheeraz Haji
Venture Partner of Rembrandt Venture Partners
Follow Sheeraz Haji:
About Rembrandt Venture Partners, zipdragon ventures: Rembrandt Venture Partners is a team of entrepreneurs, company builders, and investors.
Greg Papadopoulos
Venture Partner of New Enterprise Associates
Follow Greg Papadopoulos:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Ben Narasin
Venture Partner of New Enterprise Associates
Ben Narasin is a Venture Partner at NEA. A prolific entrepreneur and highly regarded early-stage investor with three decades of company-building expertise, Narasin has focused on emerging technologies and new markets throughout his investment career. With a portfolio comprising key early successes in some of today’s fastest growing sectors, such as fintech, digital marketplaces, mobile and connected devices. His overarching focus in seeking new investments is, in his words, “to find founders who make me say wow.” Narasin is a 25-year entrepreneur and 10-year early-stage investor. His knack for spotting emerging trends led him to make seed investments in companies like Dropcam, Lending Club, TellApart, Kabbage and Zenefits. Before NEA, Narasin most recently served as a General Partner at Canvas Ventures, and was previously with TriplePoint Capital, where he oversaw the firm’s seed funding investment activities. Like many of NEA’s partners, Narasin’s path to investing is rooted in entrepreneurship. He founded several consumer companies before launching his investing career, including Fashionmall.com, one of the first e-commerce companies, which he founded in 1993 and led to a successful IPO in 1999. Narasin frequently writes and speaks about technology and investing, as well as food and wine, a lifelong passion. He holds a B.A. in Entrepreneurial Studies from Babson College
Follow Ben Narasin:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Robert Garland
Venture Partner of New Enterprise Associates
Dr. Garland joined NEA in 2003 and invests in biopharmaceuticals and medical devices. He is a director of 3-V Biosciences, Cardioxyl Pharmaceuticals, Trevena, Inc., and Zyngenia, Inc. Prior to NEA, in addition to clinical practice at the University of California, San Francisco (UCSF), he was with McKinsey & Company’s Pharmaceutical & Medical Products and Corporate Finance & Strategy practices. At McKinsey, Dr. Garland worked with biotech, pharmaceutical, medical device, diagnostics, and private equity clients to evaluate investments, formulate product and corporate strategies and build businesses. Dr. Garland completed his Residency in Internal Medicine and Fellowship in Infectious Diseases at UCSF and received his MBA and MPH from the University of California, Berkeley, his MD from Baylor College of Medicine, and his BS in EE/Bioengineering from Rice University.
Follow Robert Garland:
About Cardioxyl Pharmaceuticals, NEAD, New Enterprise Associates, Trevena, Zyngenia: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Mike O’Dell
Venture Partner of New Enterprise Associates
Mike joined NEA in 2002 as a Venture Partner. His primary interest is the structure and behavioral dynamics of large, complex systems. He currently advises NEA portfolio companies Glacier Bay, Neutral Tandem, and Vonage. Mike came to NEA from UUNET Technologies where he was Chief Scientist, responsible for network and product architecture during the emergence of the Commercial Internet. Prior to UUNET, Mike held positions at Bellcore (now Telcordia), a GaAs SPARC supercomputer startup, and a US Government contractor. Mike served for four years as Area Director for Operations and Management in the IETF, authored several IDs and RFCs, and helped birth RADIUS and SNMPv3. Mike received his BS and MS in Computer Science from the University of Oklahoma.
Follow Mike O’Dell:
About Nealite, New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Jeff Immelt
Venture Partner of New Enterprise Associates
Immelt has held several global leadership positions since coming to GE in 1982, including roles in GE’s Plastics, Appliances, and Healthcare businesses. In 1989 he became an officer of GE and joined the GE Capital Board in 1997. Immelt has been named one of the World’s Best CEOs three times by Barron’s, and since he began serving as chief executive officer, GE has been named America’s Most Admired Company in a poll conducted by Fortunemagazine and one of The World’s Most Respected Companies in polls by Barron’s and the Financial Times. Immelt was the chair of President Obama’s Council on Jobs and Competitiveness. He is a member of The American Academy of Arts & Sciences. Immelt earned a B.A. degree in applied mathematics from Dartmouth College in 1978 and an M.B.A. from Harvard University in 1982. He and his wife have one daughter.
Follow Jeff Immelt:
About GE Appliances, GE Healthcare, GE Plastics, New Enterprise Associates, Stanford Graduate School of Business: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Brooke Seawell
Venture Partner – Menlo Park of New Enterprise Associates
Brooke joined NEA in 2005 as a Venture Partner, focusing on software and semiconductor investments. Brooke currently serves on the board of directors of Glu Mobile (NASDAQ: GLUU), SiTime, SugarCRM, and Tableau Software. He also works closely with Tabula. He brings 25-plus years of experience in technology finance and operations. Brooke was most recently a Venture Partner with Technology Crossover Ventures (TCV). Prior to that, he was Executive Vice President of NetDynamics, an application server software company, which was acquired by Sun Microsystems in 1998. From 1991 to 1997, Brooke was Senior Vice President, Finance and Operations and CFO of Synopsys, an electronic design automation software company, which he took public in 1992. During his tenure at Synopsys, revenue grew from $20 million to $500 million. From 1983 to 1991 Brooke served as Vice President, Finance and Production and CFO of Weitek, a fabless semiconductor company, which he took public in 1988. Previously, he co-founded and was CFO of Southwall Technologies, a complex thin film coatings company. In 1990, Brooke was recognized by Upside magazine as one of the top 15 high-tech CFOs. He currently serves on the board of three public companies (NVIDIA, Informatica and Glu Mobile) and a variety of private companies. Brooke also serves on the Management Board of the Stanford Business School. He received his MBA and BA from Stanford University.
Follow Brooke Seawell:
About Formative Ventures, New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Ron Bernal
Venture Partner of New Enterprise Associates
Ron is an entrepreneur and business executive who spent the first 24 years of his career in the high-technology operating world and the last 11 years as a venture capitalist. He joined NEA in 2010 as a Venture Partner and focuses on information and energy technology investments. He currently serves on the boards of Boulder Wind Power, Cohere Technologies, Gainspeed, Ketra, Kumu Networks, Leyden Energy and Solidfire and works closely with HelioVolt and Blue Jeans Network. Previous board memberships include Data Domain (acquired by EMC), Drobo (merged with Connected Data) HelioVolt, LifeSize (acquired by Logitech), Indicative (acquired by Nimsoft), Nicira (acquired by VMware), ProStor (acquired by Imation and Tandberg) and Redseal Systems. Prior to NEA, Ron was a Partner at Sequel Venture Partners and led the firm’s investments in HelioVolt and Buzzwire. Ron previously served as a Venture Partner at Sutter Hill Ventures, where he led the firm’s investments in Data Domain, Drobo, ProStor, LifeSize, Indicative and Redseal Systems. Prior to Sutter Hill Ventures, he was Chief of Staff/COO for the Service Provider and Product Technology Group Businesses at Cisco. He joined Cisco as part of the Growth Networks acquisition in 2000, where he was President and CEO. Ron co-founded Growth Networks, an internet switching fabric company, in 1998 while serving as an entrepreneur-in-residence at NEA. Prior to working with NEA, he spent more than seven years with Silicon Graphics, Inc. (SGI) in roles including Senior Vice president and General Manager of the $1 billion-plus server division and President of the MIPS group, the microprocessor subsidiary of SGI. Ron was also Vice President of Engineering and COO of Edge Computer, a computer company he co-founded in 1983. Ron also serves on the boards of Open Network Summit (ONS), Energy Fellows Institute, Colorado School of Mines Advisory, Colorado State University Ventures, and NREL VC advisory board. He holds a B.S. in electrical engineering from DeVry Institute of Technology.
Follow Ron Bernal:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Carol Gallagher
Venture Partner of New Enterprise Associates
Carol Gallagher joined NEA in October, 2014. She is primarily focused on biopharma investments. Carol is a proven entrepreneur, operator and more recently investor with more than 25 years of experience in commercial, drug development and business development roles. Prior to joining NEA she was a Venture Partner with Frazier Healthcare and she served as an independent director on multiple Boards including Aragon Pharmaceuticals, which was acquired in 2013 by Johnson and Johnson for $650 million upfront and a total consideration of $1 billion. From 2008-2011, Dr. Gallagher was the president and CEO of Calistoga Pharmaceuticals that developed the first-in-class cancer therapeutic, CAL-101, now known as ZYDELIG. During her tenure as CEO at Calistoga Pharmaceuticals, Dr. Gallagher raised $80 million in venture financing and led the company to a successful exit with the acquisition by Gilead Sciences in April 2011 for $375 million and a total consideration of $600 million. Gilead has continued to rapidly advance registration trials of ZYDELIG in patients with certain types of leukemia and lymphoma. In 2014, ZYDELIG was approved in the US and Europe for three indications simultaneously.
Follow Carol Gallagher:
About GlaxoSmithKline, New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Jay Graf
Venture Partner of New Enterprise Associates
Jay Graf joined NEA in October 2005 as a Venture Partner focusing primarily on medical device investments. Jay comes to NEA after nearly 30 years experience in the healthcare industry. He currently serves on the boards of American Medical Systems, Anulex Technologies, CVRx, Denali Medical, Ivantis, Rotation Medical and VytronUS. Most recently, Jay was Group Chairman of Guidant where he directed Guidant’s four operating groups before retiring in 2004. From 1992-2000, Jay was President of Guidant’s Cardiac Rhythm Management Group, now owned by Boston Scientific. Prior to that, he was Executive Vice President and COO of CPI from 1990 to 1992. Jay held a variety of management positions with Eli Lilly’s Pharmaceutical and Medical Device Division between 1976 and 1990. He is a graduate of Boston University with a Bachelor of Science degree in Business and Economics, and earned a Masters in Business Administration degree in finance from Indiana University. Jay served in the United States Air Force where he achieved the rank of Captain.
Follow Jay Graf:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Hilarie Koplow-McAdams
Venture Partner of New Enterprise Associates
Hilarie joined NEA in 2017 as a Venture Partner on the technology team, where she focuses on enterprise software and services. An enterprise software veteran, Hilarie spent the last three decades at growth-stage technology companies in operating and board roles. Most recently, Hilarie was President at New Relic, responsible for New Relic’s growth strategies, as well as leading global sales, marketing, customer success, support, and business development. Prior to New Relic, Hilarie was at Salesforce, where she was President and led the company’s worldwide sales teams and focused on growing the business globally. Hilarie joined Salesforce from Intuit, where she was Vice President of direct sales for small business and a member of the executive committee.
Follow Hilarie Koplow-McAdams:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Arno Penzias
Venture Partner of New Enterprise Associates
Arno Penzias joined New Enterprise Associates (“NEA”) in 1997 as a Venture Partner from Bell Labs, where he headed its research organization and served as its Chief Scientist.Arno is currently on the Board of HelioVolt and Terrajoule and serves as technical adviser, as needed, for a number of NEA companies, including: Bloom Energy, HelioVolt, Hillcrest Laboratories, Solar Junction, SolFocus, Spreadtrum Communications, Telegent Systems and Tri Alpha Energy. He has written two books and a number of articles on science and technology, especially their impact on business and society.A member of both the National Academy of Sciences and the National Academy of Engineering, he received a BS from City College of New York and a PhD from Columbia University.His awards include a number of honorary degrees, as well as other awards, for his contributions to science, R&D management and public service – most notably the 1978 Nobel Prize in Physics for his work in radio astronomy.
Follow Arno Penzias:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Elliott Sigal
Venture Partner of New Enterprise Associates
Elliott Sigal, M.D., Ph.D. joined NEA as a Venture Partner and Senior Advisor in 2014. He is a former Executive Vice President and Director of Bristol-Myers Squibb, and served as Chief Scientific Officer and President of R&D for Bristol-Myers Squibb from 2004 until 2013. He was a principal architect of the successful Biopharma Transformation Strategy of the company. He has been instrumental in increasing R&D productivity, developing the company’s strategy in biologics and acquiring external innovation in Bristol’s String of Pearls initiative. Under his leadership, fourteen new medicines have come to market including Abilify (Schizophrenia, Bipolar Disorder), Reyataz (HIV/AIDS), Erbitux (Colon Cancer), Baraclude (Hepatitis B), Orencia (Rheumatoid Arthritis), Sprycel (Leukemia), Atripla (HIV/AIDS), Ixempra (Breast Cancer), Onglyza and Kombiglyze (Diabetes), Nulojix (Transplantation), Eliquis (Anticoagulant), Yervoy (Melanoma), and Forxiga (Diabetes). Among his accomplishments in various therapeutic areas was building BMS research into a lead position in the promising area of immuno-oncology. In 2012, Dr. Sigal was named the best R&D chief in the pharmaceutical industry by Scrip Intelligence. Dr. Sigal currently serves as a senior advisor to the healthcare team of New Enterprise Associates and also consults for select biotechnology companies. Dr. Sigal received his M.D. from the University of Chicago in 1981 and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco (UCSF). Prior to medical school he studied engineering at Purdue University, where he received a B.S., M.S., and Ph.D. Dr. Sigal serves as a member of the Board of Directors for the Mead Johnson Nutrition Company and the Melanoma Research Alliance.
Follow Elliott Sigal:
About Amgen, New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Kavita Patel
Venture Partner of New Enterprise Associates
Follow Kavita Patel:
About New Enterprise Associates, The Brookings Institution, The World Economic Forum: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Steve Reale
CFO & Venture Partner of Ulu Ventures
Steve Reale joined Ulu Ventures as CFO and Venture Partner in 2019.
Follow Steve Reale:
About Aria Systems, Kauffman Fellows, Madison Bay Capital Partners, Midwestern Bioag, ShotSpotter, Ulu Ventures: Ulu Ventures provides early-stage investments to enterprise cloud and smart data companies.
Everett Cox
Venture Partner of Emergence
Venture Partner at Emergence Capital & Board Member at Digital Air Strike.
Follow Everett Cox:
About Emergence, Fargo Electronics: Emergence is a venture capital firm, investing in early and growth-stage cloud and SaaS visionaries that change the way the world works.
Wray Thorn
Venture Partner of Two Sigma Ventures
Wray Thorn joined Two Sigma in May 2012 and leads the company’s Private Investments and Ventures businesses. Wray has spent his career identifying, financing, structuring, and investing in private investment transactions and management buyout transactions, including being involved in 17 stand-alone management buyouts, 37 add-on acquisitions, realizations, corporate financings, fundraisings and other principal transactions, and 10 leverage financings totaling approximately $25 billion in aggregate consideration. Prior to joining the company, Wray was a senior managing director with Marathon Asset Management, L.P., where he developed and led the company’s private equity business and a number of other new business opportunities, investor-related activities and capital formation initiatives. Prior to Marathon, Wray worked as a director with Fox Paine & Company, LLC and as a principal with Dubilier & Company, LLC. He began his career in the Acquisition Finance Group at Chemical Bank (today, JPMorgan Chase) financing corporate and private equity-sponsored acquisitions. Wray has served as a member of the Board of Directors and various Board committees of 12 public and private companies. In 1993, Wray graduated with an A.B. in government (cum laude) from Harvard University.
Follow Wray Thorn:
About Two Sigma Ventures: Two Sigma Ventures is an early-stage venture capital fund that invests in companies run by highly driven people.
Serge Plotkin
Venture Partner of Opus Capital
Serge Plotkin is a venture partner for Opus Capital, where he sources and evaluates investment opportunities and contributes technical assistance to portfolio companies. Serge is also an associate professor of Computer Science at Stanford University, where he has served since 1989. Together with Opus Capital General Partner Dan Avida, Serge co-founded Decru in 2001 where he served as chief technology officer and vice president of engineering. Serge has published more than a hundred technical papers and has been issued fourteen patents. He served as the vice chair of the Security in Storage Workgroup P1619/P1619.1, IEEE standardization committee, which is tasked with creating a standard for storage encryption, and is the editor of the IEEE1619 standard. Serge obtained a Ph.D. in Computer Science from MIT and BSc and MSc degrees in Electrical Engineering from Ben Gurion University, Israel. Before his studies at MIT, Serge served for five years as an officer in the Israel Defense Forces.
Follow Serge Plotkin:
About Edunav, Engageli, Opus Capital, Stanford University: At Opus Capital, they are energized and excited about venture investing. The outlook for early-stage technology companies.
Bill Youstra
Venture Partner of Kohlberg Ventures
Bill Youstra focuses on mobile commerce and media, both as a Venture Partner for Kohlberg Ventures and as an independent advisor to early stage companies. Most recently he was SVP of Marketing & Business Development for Revel Touch, a tablet e-commerce pioneer, where he helped shape the company’s early strategy, secure funding and build out business operations. Past operating & consulting roles include SocialChorus, thefind.com, there.com, Pixo and AOL, where he oversaw network-level programming & promotions, subscriber relations, email, search, software UX and other areas with over 5bn monthly impressions and $750m annual contribution. Bill holds an MBA from Stanford University, where he contributed to the best-selling book “Built to Last” by Jim Collins and Jerry Porras. He also holds an MA in Education from Stanford and B.A. Film, B.S. Computer Science and B. A. Marketing from the University of Maryland. He lives with his wife and four boys in Portola Valley, CA.
Follow Bill Youstra:
About Kohlberg Ventures, MyAlerts: Founder is chairman of Halogen Network (and also chairman of private equity firm Kohlberg & Company).
Brian Nichols
Venture Partner, Squad Leader of Hustle Fund
Brian Nichols is Co-Founder at RewardTag.
Follow Brian Nichols:
About Hustle Fund: Hustle Fund is a seed fund that seeks to invest in early-stage startups.
Umesh Padval
Venture Partner of Thomvest Ventures
Umesh Padval is a partner at Thomvest partner at Thomvest Ventures in San Francisco, California. He focusses on venture capital investments in cybersecurity and cloud infrastructure. He currently serves on the private company boards of Bolster, Shiftleft, Clari, Shield X, Avalanche Technology and Tactus and public company board of Impinj. He is also an investor in Baffle and Harness.He has extensive board experience serving on over 30 public and private company boards and several audit, compensation and nominating and governance committees. Prior to joining Thomvest, Umesh was a successful entrepreneur, investor and CEO of a public company. He most recently worked for over 8 years at Bessemer Venture Partners in their office in Menlo Park. Prior to Bessemer, he worked as an executive vice president at LSI after its acquisition of a public video infrastructure and distribution company, C-Cube Microsystems. At C-Cube, Umesh served as president and CEO and grew the company profitably to over $300m in revenue and 500 employees with a global presence. Previously he was a Board Member at Lastline(Private,Sold to VMware),Blue Willow Systems (Private, Sold to Philips), Avnera (Private, Sold to Skyworks), Skyhigh Networks (Private, Sold to McAfee), Mellanox (Public, Sold to Nvidia), IDT(Public, Sold to Renesas), C-Cube Microsystems (Public, Sold to LSI), Entropic Communications (Public, Sold to Maxlinear), Silicon Image (Public, Sold to Lattice), Elantec (Public, Sold to Intersil), Berkeley Design Automation (Private, Sold to Mentor Graphics), Monolithic Power Systems (Public), Tilera (Private, Sold to EZchip) and PA Semi (Private, Sold to Apple). He was also an investor in Thousand Eyes( Private, Sold to Cisco) and Cylance( Private, Sold to Blackberry). Umesh holds a Bachelor’s in Technology from Indian Institute of Technology, Mumbai and a Master’s in Engineering from Stanford University. He has served on several advisory boards at Stanford University and currently serves on the board of Palo Alto Medical Foundation and Sutter Medical Group.
Follow Umesh Padval:
About Thomvest Ventures: Thomvest Ventures provides companies with cross-stage venture capital fund.
Jonathan Barker
Venture Partner of Thomvest Ventures
Jonathan’s diverse background includes managing the China subsidiaries of two Fortune 500 companies: Commercial Metals Company and EchoStar Communications Corporation; co-founding a Silicon Valley-based video search technology company – MeeVee – as well as developing strategic marketing and distribution plans, structuring and negotiating financial and commercial transactions, and carrying out due diligence for more than two dozen multinational companies and investment banks. Jonathan sits on the board of Tactus Technology. He holds a Master’s degree in East Asian Studies from Harvard University and a Bachelor’s degree in Chinese from the University of Wisconsin-Madison.
Follow Jonathan Barker:
About EchoStar, Thomvest Ventures: Thomvest Ventures provides companies with cross-stage venture capital fund.
Bob Pape
Venture Partner of Thomvest Ventures
Bob Pape is an Operating Partner at Thomvest, advising portfolio companies on financial and operational best practices. He has served as CFO of several high-tech venture-backed companies, most recently NetBase Solutions, a leading social media analytics company. Bob has managed 3 IPO’s, a secondary offering and several early and late-stage Venture Capital financings. He has managed the acquisition and sale of companies, products, divisions and product lines. In addition to the traditional CFO role, Bob has a wide-range of experience, having served as CEO, COO, Division General Manager and SVP-Manufacturing at various times. In addition to Thomvest, Bob has worked with investors and Board members of several prominent venture capital firms including Kleiner Perkins, Sequoia Capital, Sierra Ventures, Austin Ventures and Granite Global. Bob has a BSBA degree from Rockhurst University in Kansas City, MO.
Follow Bob Pape:
About Tactus Technology, Thomvest Ventures: Thomvest Ventures provides companies with cross-stage venture capital fund.
Greg Rosen
Venture Partner of BoxGroup
Follow Greg Rosen:
About BoxGroup: BoxGroup is an early-stage investment fund that invests in technology companies.
Josh Manchester
Venture Partner of Foundation Capital
Josh loves studying companies or trends which have touch points with governance or with large industries or parts of society that are off the Silicon Valley radar. He previously founded Champion Hill Labs, which performed consulting services for venture firms and hedge funds, and through which he invested in SpaceX, Flexport, and Rigetti Computing. Before that he cut his teeth in the venture industry during six years on the team at TrueBridge Capital Partners, committing about $1 billion to venture capital firms globally as an LP, and leading the team’s investments in several mid-stage companies. He began his career in finance at USAA Real Estate Company. Before becoming an investor, Josh spent about six years as an officer in the US Marine Corps, in infantry and combat engineering roles, and has led three different platoons ranging from 10-60 Marines. In his last role he led a reinforced rifle platoon and was responsible for the security and civil development of a city of 10,000 people along the Euphrates River. He graduated from Duke University. When not chasing his young kids he enjoys Alan Furst novels and any time spent in the great outdoors.
Follow Josh Manchester:
About Creative Destruction Lab (CDL), Foundation Capital: Foundation Capital is a venture capital firm made up of former entrepreneurs and helps companies and businesses grow.
Ted Kummert
Chief Product Officer in Residence and Venture Partner of Madrona Venture Group
Ted joined Madrona in 2013 and brings his years of technical and operational leadership in enterprise technology to Madrona and the portfolio companies. As Venture Partner, Ted identifies new investments and provides strategic counsel and operational advice to Madrona portfolio companies. Prior to Madrona, Ted drove major product and business initiatives for Microsoft for more than two decades. At Microsoft, Kummert led teams across a broad set of technologies, including operating systems, consumer online services, enterprise security and enterprise application platform. As Corporate Vice President of the Data Platform Group, Kummert led the development of several key Microsoft enterprise products including SQL Server, SQL Server Parallel Data Warehouse, Windows Azure Data Services and Microsoft’s business intelligence and big data offerings. Widely known as the “data chief” of Microsoft, he led the data platform business through a period of significant growth and drove the cloud and big data strategy for the platform. Ted began his career at Apple and HP.
Follow Ted Kummert:
About Madrona Venture Group, UiPath: Madrona Venture Group is a venture capital firm that invests in early-stage technology companies.
Trevor Baglin
Venture Partner of Medicxi Ventures
Trevor is a Venture Partner in the investment team with main focus on growth stage clinical opportunities. Prior to joining Medicxi, he was a Consultant Haematologist at Cambridge University Hospitals for 27 years. His main research interests were in personalised risk profiling and the molecular basis of blood coagulation, which ultimately led to his interest in drug discovery and development. He was a Founder and Director of Xo1, Apcintex and SuperX. Trevor served as President of the British Society for Haematology, President of the British Society for Haemostasis and Thrombosis and Chairman of the British Committee for Standards in Haematology. He was a Founder of the European Congress for Thrombosis and Haemostasis. Between 2001 and 2008 he led the introduction of Clinical Governance into Cambridge University Hospitals and latterly was a Divisional Director. Trevor led an internationally recognised clinical research team investigating the gene-environment interaction leading to thrombosis. He has published more than 200 scientific papers. He qualified in medicine from the University of Manchester and obtained his PhD from the University of Birmingham. He is a Fellow of the Royal College of Physicians and the Royal College of Pathologists.
Follow Trevor Baglin:
About ApcinteX, Medicxi Ventures, Medicxi Ventures, SuperX: Medicxi is a life sciences-focused investment firm.
Evan Cohen
Venture Partner of Human Ventures
Follow Evan Cohen:
About hostelworld.com, Human Ventures: Human Ventures is a business creation platform, comprised of a venture fund, studio and enterprise agency.
Pete Daffern
Venture Partner of Octopus Ventures
Peter M. Daffern, also known as Pete, serves as a Venture Partner at Octopus Investments Limited and helps UK-based portfolio to establish in the United States. He also serves as Venture Partner at Octopus Venture Ltd. Peter Daffern has been the Chief Executive Officer of ForeSee Results, Inc. since January 14, 2016. He served as Chief Executive Officer of Answers Cloud Services since January 2016 (formerly Forsee and WebCollage) where he is responsible for developing this APAX Partners asset into a world leading SaaS company. He served as President of EMEA and Executive Vice President of Verticals at NetSuite Inc., since May 9, 2013. Peter Daffern oversaw direct and channel sales and business operations in the EMEA region and direct NetSuite’s vertical strategy. He served as the Chief Executive Officer of Monitise Americas, Inc. since January 2009. He served as the President of Group Business Development at Monitise plc. Peter Daffern served as the Chief Executive Officer and President of ClairMail, Inc. since January 2009 to June 2012. Peter Daffern has over two decades of experience in leadership positions at global technology firms and has an extensive experience in leading companies. He has a wealth of technology business expertise and has strategic proficiency in North America and beyond. He served as the President and Chief Operating Officer of AIM Technology. He served as Chief Executive Officer and President of Purisma, Inc., since October 2005 until January 2009. Before AIM, he served as Vice President of Worldwide Alliances, Business Development and Corporate Development of Vitria Technology, Inc. He joined Vitria as Vice President of Worldwide Alliances on June 19, 2000. Peter Daffern has an extensive background in business intelligence (BI), business process management (BPM), enterprise application integration (EAI) and customer contact center technologies. Prior to that, Peter Daffern worked at Seagate Software more than 10 years and served a series of senior sales and business development roles culminating and served as Vice President of Europe, Middle East and Africa, where he served numerous management and sales positions including General Manager EMEA. He worked at Holistic Systems as Western Regional Sales Director and served as Sales Manager of Northern Europe. He serves as Chairman of the Board at SynchHR. Peter Daffern served as Chairman and Director of Purisma, Inc. He serves as a Director of Amplience and Revoo. He has been a Non-Executive Director of Curlet Limited since October 16, 2014 and provides leadership in helping Amplience navigate the rapidly increasing market for its rich digital media solutions. He serves as Executive in Residence for Octopus Ventures. He has been Director of Answers Corporation since May 31, 2017. He served as a Director of Market Metrix. He serves as a Member of Board of Advisors of Enablon SA. He has been a Member of Board of Advisors at Enablon North America Corp., since October 19, 2015. He holds an American and British passport, is a keen golfer and avid cyclist. Peter Daffern graduated from Sheffield University in England with a B.Sc. (Hons) in Mathematics. Collapse Detail
Follow Pete Daffern:
About Acumatica, Glofox, GroupBy, Octopus Ventures, PeakSpan Capital, Vitruvian Partners: Octopus is a multi stage European venture capital investor specializing in health, money, deep tech, and consumer.
John Hamm
Venture Partner of Octopus Ventures
John Hamm‘s career spans 35 years in technology executive (CEO) leadership, venture capital, and advisory work with CEOs and Executive Teams. John is actively engaged with a diverse group of CEOs from a variety of market segments on matters of strategy, leadership, and managing teams, change, and growth. He has coached and advised over 75 CEOs in the last decade. Previously, John served as CEO of Accept Software which he guided to acquisition by Artemis. Prior, John was a Venture Partner at Redpoint Ventures and a GP at VSP Capital in San Francisco. John was also a Partner with Geoff Moore at Chasm Group Advisors, a leading technology market strategy firm. John was CEO of Whistle Communications, funded by IVP and Mayfield. Whistle was acquired by IBM in June, 1999. John’s best-selling book, Unusually Excellent, (Wiley 2010) is available worldwide and his timeless article, The Five Messages Leaders Must Manage, was the lead feature in the May, 2006 issue of The Harvard Business Review. Hamm also authored Why Entrepreneurs Don’t Scale, for HBR in December 2002, which is used in many MBA programs worldwide. John holds a BS degree in Engineering from Purdue University in Engineering Physics and Engineering Management.
Follow John Hamm:
About Octopus Ventures, VSP Capital: Octopus is a multi stage European venture capital investor specializing in health, money, deep tech, and consumer.
Catherine Ulrich
Venture Partner of FirstMark
Catherine Ulrich, a Managing Director of FirstMark Capital, invests in a broad range of enterprise and consumer start-ups. She has a deep passion for and expertise in health and wellness, AI, and behavior change. Prior to joining FirstMark, she was the Chief Product Officer at Shutterstock (NYSE: SSTK) where she was responsible for product strategy and execution across all of Shutterstock’s offerings and brands including the company’s move into machine learning/computer vision and creative editing tools. She was also the first Chief Product Officer at Weight Watchers (NYSE: WTW), responsible for their global digital and retail experiences. Catherine holds an AB in Engineering and a certificate in Public Health Policy from Harvard College.
Follow Catherine Ulrich:
About FirstMark, LTK: FirstMark Capital is an early-stage venture capital firm that partners with exceptional entrepreneurs.
Scot Jarvis
Venture Partner of Oak Investment Partners
Scot Jarvis, Venture Partner, joined Oak in 1999 as a Venture Partner after a highly successful career in management and investment roles in the wireless communications industry. A graduate of the University of Washington, Scot founded and served as the first President of Nextlink Communications, served as a Regional President of Nextel, and served as a Senior Executive with McCaw Cellular (now AT&T Wireless). More recently, Scot was the Founder of Cedar Grove Investments, a private equity firm with a focus on wireless communications. He has served or currently serves on the boards of public and private companies, including Airspan, Good Technology, Kratos Defense, MobiTV, RootMetrics, Security Solutions, Toba Inlet PCS, and Vitesse Semiconductor. Scot focuses on Oak’s investments in the wireless communications market.
Follow Scot Jarvis:
About Airspan Networks, Kratos Defense and Security Solutions, Oak Investment Partners, Slingshot Sports: Oak Investment Partners is a multi-stage venture capital and private equity firm.
John Beletic
Venture Partner of Oak Investment Partners
John D. Beletic, Operating Partner, joined the Oak team in 2002 and is currently serving as Executive Chairman at XIO after service as Chief Executive Officer for three years. John also serves on the board of portfolio company, Cheddar’s Casual Cafe. In addition, he serves on the boards of Accent Health, iPass Inc and Tessco Technologies. Previously, John was the President and Chief Executive Officer of Tigon, PageMart, and Weblink Wireless. He was also a Venture Partner with Morgan Stanley Venture Capital Group. John received a BSBA in Finance summa cum laude from Xavier University and an MBA with high distinction from the Harvard Business School.
Follow John Beletic:
About J5 Infrastructure Partners, Oak Investment Partners, Sharablee, TESSCO: Oak Investment Partners is a multi-stage venture capital and private equity firm.
Kathy Roland
Venture Partner of Oak Investment Partners
Kathryn A. Roland, Venture Partner, joined the Oak Minneapolis office in 2002 on a part-time basis after 18 years of experience working with retail and services businesses. Her functional expertise includes strategic planning, acquisitions, new business development, market analysis, and retail site selection. Through both corporate positions and consulting engagements, Kathy has worked with a variety of retailers, from venture-backed start-ups to major corporations such as Target and Marshall Fields. Kathy received her BA from Carleton College and her MBA from The Wharton School, University of Pennsylvania.
Follow Kathy Roland:
About Oak Investment Partners: Oak Investment Partners is a multi-stage venture capital and private equity firm.
Saad Gómez
Venture Partner of Oak Investment Partners
Saad Gómez, Venture Partner, began with Oak in 2011 and became a Venture Partner in 2014. He currently focuses on Oak’s strategic opportunities in key emerging markets. Angel has a wide range of industry experience in technology, energy, consumer internet, finance, logistics, communications, and consumer packaged goods. He works closely with several Oak portfolio companies including eSolar, NowThis, Airspan, Mimosa Networks, Limelight Networks (NSDQ: LLNW), FRS, and on an ad hoc basis with other portfolio companies. Angel has a finance and consulting background, having advised Fortune 500 and technology companies, and family offices. A native of Mexico, he has served in several advisory capacities to the Mexican Government and with Mexico’s National Autonomous University (UNAM), a top international research institution, in their ecosystem development initiatives. Angel actively contributes to developing ecosystems in key emerging markets around the world. Angel holds a BA from Stanford University, where he rowed for Stanford’s Crew team.
Follow Saad Gómez:
About Oak Investment Partners: Oak Investment Partners is a multi-stage venture capital and private equity firm.
Wei Jiang
Venture Partner of ZhenFund
Follow Wei Jiang:
About ZhenFund: ZhenFund invests in TMT, healthcare, and education among other sectors.
Gus Tai
Venture Partner of Trinity Ventures
Follow Gus Tai:
About Bulletproof, Ten Percent Happier, Trinity Ventures: Trinity Ventures is an early stage venture capital firm.
William Norvell
Venture Partner of Sovereign’s Capital
Follow William Norvell:
About AMDG Capital, Sovereign’s Capital: Sovereign’s Capital provides growth capital for consumer SaaS, B2B tech, healthcare IT, and med devices.
Russell Bjorkman
Venture Partner, General Counsel of Sovereign’s Capital
Follow Russell Bjorkman:
About Lighthouse, Sovereign’s Capital: Sovereign’s Capital provides growth capital for consumer SaaS, B2B tech, healthcare IT, and med devices.
Julie Hanna
Venture Partner of Obvious Ventures
Julie is an entrepreneur, board director, investor and advisor to companies and public institutions globally. She has been founder, CEO and founding executive of five successful technology companies in Silicon Valley, giving her a deep understanding of b2b and b2c businesses from startup to scale-up. In recognition of her groundbreaking work and leadership as an entrepreneur and innovator, President Obama appointed Julie Presidential Ambassador for Global Entrepreneurship in 2015. Since 2009, she has served as Executive Chair of the Board at Kiva, the first and largest crowdlending marketplace for entrepreneurs. During her tenure, Kiva has scaled its reach to 190+ countries and facilitated over $700 million loans to 1.6 million entrepreneurs. Julie is also an active investor and advisor to high-growth technology companies, including sharing economy pioneer Lyft, Lending Club (NASDAQ: LC), the world’s largest online marketplace connecting borrowers and investors, online retail innovator Bonobos, and technology incubator Idealab, creator of over 125 companies with 40 IPO’s and acquisitions. She was special advisor to Plum, the first private social network, from its founding to the acquisition by Nokia and she served on the board of directors of enterprise social networking pioneer Socialtext, until its acquisition by PeopleFluent. Previously, Julie was the founder and CEO of Scalix, a leading open source and pioneering freemium email/collaboration platform for businesses that quickly established a global footprint in 55 countries. Julie founded Scalix while an Entrepreneur in Residence at Mayfield Fund, where she advised the firm on technology investments. Earlier in her career, Julie was the founding Vice President of Products & Marketing serving until the company’s $850M acquisition by phone.com (NASDAQ: UPIP). At Onebox, she led the design and development of the first mass scale consumer VoIP platform, and launched the fastest growing dot com era communications service, reaching 5 million users in its first year of operation. Julie was also founding Vice President of Products & Marketing at 2Bridge Software, naming and establishing the “enterprise portal” category, and she was founding Vice President of Products & Marketing at Portola Systems, where she was instrumental in the successful sale of the company to Netscape. Portola’s product went on to become Netscape Mail and subsequently the SunOne Mail platform. In 1995, Julie was recruited as part of the founding team to help Jim Clark build the first healthtech company, Healtheon now WebMD (NASDAQ: WBMD), the largest healthcare portal in the world. She started her career in technical and product roles at IBM/Lotus and Silicon Graphics, where she conceived WebForce Intranet, a new business and product line that helped catapult the company to the forefront of the internet revolution in 1995. At IBM/Lotus, she played a prominent role in shaping the next generation product and marketing strategy for cc:Mail and Lotus Notes and authored the manifesto, “Groupware: Communication, Coordination & Collaboration”. Julie is a member of the World Economic Forum Global Agenda Council on Humanitarian Response. She is a regular international keynote speaker and guest lecturer at Stanford, Cambridge and Oxford Universities on entrepreneurial leadership and innovation. She holds a B.S. in Computer Science from the University of Alabama at Birmingham, where she has been honored as Distinguished Alumni of the Year and was Graduation Commencement Speaker. She lives on the top of a hill in San Francisco. —————————————- She is an advisor to Idealab and a number of startups and social businesses in the US and Europe. Having helped create products that have been adopted by tens of millions over the past two decades, Julie likes to work with products that have the potential to reach mass scale. Her focus areas include consumer internet, enterprise 2.0, mobile, email and communications, e-commerce, e-tailing, social networking & gaming. Previously, Julie launched and helped build five consumer internet and software companies. As an entrepreneur-in-residence at Mayfield, she founded and served as CEO of Scalix, developer of a commercial open source messaging platform and the industry’ss first AJAX rich mail & calendaring client. Scalix achieved global adoption, with two million accounts in 65 countries and garnered many industry awards, leading to it’s acquisition by Sebring. Stanford and Harvard Business Schools have published case studies on Scalix. Before Scalix, Julie was founding VP of Products & Marketing at several startups: onebox.com, ($850M acquisition by OpenWave Nasdaq; OPNWV) the fastest growing internet communications service in 1999; 2Bridge, where she coined the term ‘enterprise portal’ and successfully championed the creation of a new software category; and Portola, where she was instrumental to the acquisition by Netscape. Prior, she was the first product manager at Healtheon where she brought to market market the industry’s first secure web-mail service at Healtheon, now WebMD (Nasdaq: WBMD).
Follow Julie Hanna:
About Bonobos, Lending Club, MightyText, Obvious Ventures, US Department of Commerce, Economic Development Administation: Obvious Ventures is a venture capital firm that invests in the early and growth stages.
Andrew Hong
Venture Partner of ff Venture Capital
Andrew currently serves on the investments team at ff Venture Capital and focuses on areas of interest such as A.I., fin-tech, healthcare, robotics, energy, and computing. Prior to ffVC, Andrew founded several companies in the A.I., fin-tech, and health-tech sectors. His previous experience also includes consulting for Oracle, working within Nielsen’s digital analytics division, and joining DeltaOne Solutions which was later acquired. Andrew graduated from Boston College with a B.S. in Marketing & Management Leadership.
Follow Andrew Hong:
About Dashbot, ff Venture Capital: ff Venture Capital is a technology venture capital firm that invests in cybersecurity, AI, machine learning, drones, and cloud software.
Florin Mihoc
Venture Partner of ff Venture Capital
Follow Florin Mihoc:
About ff Venture Capital: ff Venture Capital is a technology venture capital firm that invests in cybersecurity, AI, machine learning, drones, and cloud software.
Oliver Mitchell
Venture Partner of ff Venture Capital
Oliver joined ff Venture Capital in 2018 as a Venture Partner. He is the founding partner at Autonomy Ventures, a venture firm focused on early stage investments in business and industrial automation technologies, including robotics, smart mobility, remote sensing and machine intelligence. Oliver’s portfolio has returned over six exits in the past five years with two IPOs. Previous transactions have included selling Holmes Protection to ADT/Tyco, Americash to American Express, and launching RobotGalaxy, a national EdTech brand. He is an active member of New York Angels and holds 14 patents. Oliver speaks often at international trade shows and writes syndicated articles that reaches thousands of weekly readers.
Follow Oliver Mitchell:
About ff Venture Capital, New York Angels: ff Venture Capital is a technology venture capital firm that invests in cybersecurity, AI, machine learning, drones, and cloud software.
Paul Rogers
Technical Venture Partner of Next Coast Ventures
Paul Rogers is the Head of Engineering at Workrise.
Follow Paul Rogers:
About Next Coast Ventures, Workrise: Next Coast Ventures is a venture capital firm founded by entrepreneurs, for entrepreneurs in ‘Next Coast’ markets.
Jason Dorsey
Venture Partner & Entrepreneurs Council of Next Coast Ventures
Jason Dorsey is a researcher, serial entrepreneur, and keynote speaker. He has led nearly 100 research studies to uncover hidden generational trends and new behavioral insights about consumers, employees, and technology. He is President and Co-Founder of The Center for Generational Kinetics, a pioneering research and strategy firm with more than 700 clients including many of the biggest brands and pioneering startups. Dorsey has been featured on over 200 television shows from 60 Minutes to The Today Show. He wrote his first bestselling book at age 18. His newest books is Zconomy: How Gen Z Will Change the Future of Business and What To Do About It Companies that Jason founded have made the Inc 5000 list three times and he has served on both public and private company boards of directors.
Follow Jason Dorsey:
About Next Coast Ventures, The Center for Generational Kinetics: Next Coast Ventures is a venture capital firm founded by entrepreneurs, for entrepreneurs in ‘Next Coast’ markets.
James Dunham
Technology Venture Partner of Next Coast Ventures
Follow James Dunham:
About Next Coast Ventures, Wolters Kluwer Tax & Accounting US: Next Coast Ventures is a venture capital firm founded by entrepreneurs, for entrepreneurs in ‘Next Coast’ markets.
Loren Siebert
Venture Partner of Akkadian Ventures
Loren has been an early investor, technical advisor, or key employee at several early stage companies: RallyPoint, Disruption Corporation, Keen.io, Omada Health, IndieGoGo, Zozi, and Quote.com. Specializing in large-scale search and analytics systems and Agile development methodologies, Loren works with both government agencies and small startups to get commercial-quality software into production. Loren led the technical development for DigitalGov Search, an award-winning hosted SaaS search solution currently used by over 1,500 government and military sites. Previously, Loren was a lecturer at the University of California at Berkeley, where he taught Arabic. As an entrepreneur, Loren designed and built a specialized language learning program called LinguaStep that today is used by Arabic language learners worldwide in universities and high schools as well as in the Army Special Forces. Loren began his career at the National Security Agency while still in high school. He holds degrees in Computer Science from the University of Maryland and the University of Manchester, and studied technology policy at the London School of Economics as a Marshall Scholar.
Follow Loren Siebert:
About Akkadian Ventures: Akkadian Ventures is a direct secondary investment firm that offers liquidity to early employees and investors of venture-backed businesses.
Ryan Sarver
Venture Partner of Redpoint
Ryan joined Redpoint in 2013 to invest in entrepreneurs building companies at the seed, early and early growth stages. He sits on the boards of Anvyl, FLEXE, hims, and Brandless (observer). Ryan was an early employee at Twitter where he oversaw the Twitter Platform and its developer ecosystem as the service scaled globally to more than 200 million active users. Before Twitter, Ryan was director of consumer products at Skyhook Wireless, which pioneered the Wi-Fi and cellular tower triangulation technology incorporated in the Apple iPhone, iPod Touch, and MacBook. Ryan is a co-investor in Alta CA, a restaurant in San Francisco, and an amateur hockey player.
Follow Ryan Sarver:
About Redpoint: Redpoint Ventures partners with visionary founders to create new markets or redefine existing ones at the seed, early, and growth stages.
David Ritter
Venture Partner of ATX Venture Partners
David Ritter is a Former Partner at McKinsey & Company. He is now part of the Advisory Board of Pensa Systems and a Venture Partner at ATX Venture Partners.
Follow David Ritter:
About ATX Venture Partners: ATX Venture Partners is an early-stage venture capital firm investing in B2B software, APIs, frontier tech, marketplaces, and applications.
Arthur Coviello
Venture Partner of Rally Ventures
Art Coviello is Executive Vice President, EMC Corporation and Executive Chairman, RSA, The Security Division of EMC. With revenues of $21.7 billion in 2012 and 60,000 people worldwide, EMC is a global leader in enabling businesses and service providers to transform their operations and deliver IT as a service. Fundamental to this transformation is cloud computing. Through innovative products and services, EMC accelerates the journey to cloud computing, helping IT departments to store, manage, protect and analyze their most valuable asset—information—in a more agile, trusted and cost-efficient way. Coviello is responsible for RSA’s strategy and overall operations as it delivers EMC’s global vision of information-centric security. He was Chief Executive Officer of RSA Security, Inc. prior to its acquisition by EMC in 2006. He joined RSA in 1995 and has been a driving force in its rapid growth since that time. His expertise and influence have made him a recognized leader in the industry. He is frequently a featured presenter at conferences and forums around the world, and he plays key roles in several national cyber-security initiatives. He is based at RSA headquarters in Bedford, Massachusetts. Coviello has more than 30 years of strategic, operating and financial management experience in technology companies. In addition, he currently serves on the Board of Directors at EnerNOC, a leader in demand response systems for energy conservation, and AtHoc, a leading provider of enterprise class network-based mass notification systems for the security, life safety and defense sectors. He graduated magna cum laude from the University of Massachusetts.
Follow Arthur Coviello:
About Dell EMC, Rally Ventures, Technet: Rally Ventures invests in early-stage enterprise technology companies.
Tom Peterson
Venture Partner of Rally Ventures
Follow Tom Peterson:
About El Dorado Ventures, Rally Ventures: Rally Ventures invests in early-stage enterprise technology companies.
Aaron Tong
Venture Partner of Sierra Ventures
Xuesong Tong is the Group Vice President, President of TCL Venture Capital.
Follow Aaron Tong:
About Sierra Ventures, TCL Technology: Sierra Ventures is an early-stage venture firm investing globally with a focus on next generation enterprise and emerging technologies.
Joseph A. Yanchik III
Venture Partner of Apple Tree Partners
Joseph Yanchik, a venture partner at ATP, has been founding and funding life science companies for more than 20 years. In 2005, Joe founded ATP portfolio company Tokai Pharmaceuticals, focused on biopharmaceutical treatments for prostate cancer, serving as president and CEO from 2005 to 2008 and then as a director through 2017. Concurrently, Joe founded ATP portfolio company Aileron Therapeutics, focused on developing a novel class of stabilized cell-permeating peptides called stapled peptides, for cancer and other diseases. He established a $1.1 billion partnership between Aileron Therapeutics and Roche Pharmaceuticals and led Aileron from inception to public listing, serving as president, CEO, and director from 2006 to 2018. Previously, Joe served as vice president of corporate development at Mendel Biotechnology, an agricultural biotech company, and founded and served as chief financial officer of Poetic Genetics, a gene therapy company. He began his career practicing corporate and securities law at Cahill Gordon & Reindel, where he specialized in public securities offerings, high-yield debt financings, and M&A. He then moved to Venture Law Group in Menlo Park, where he specialized in financing early-stage life science and technology companies. Joe received a BBA from Loyola College in Maryland and a JD from the Villanova University School of Law, where he was managing editor of the Law Review. He is a member of the New York, California, and District of Columbia bars.
Follow Joseph A. Yanchik III:
About Apple Tree Partners: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Spiros Liras
Venture Partner of Apple Tree Partners
Spiros Liras is a Venture Partner at Apple Tree Partners.
Follow Spiros Liras:
About Apple Tree Partners, Nereid Therapeutics, Nine Square Therapeutics: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Argeris Karabelas
Venture Partner of Apple Tree Partners
Dr. Karabelas was Head of Healthcare and CEO of Worldwide Pharmaceuticals for Novartis AG from 1998 until July 2000. He had full responsibility for Novartis Pharma, Ciba Vision and Generics representing $12 billion in annual sales. Included in these responsibilities was strategic and operational leadership of R&D with a budget in excess of $2 billion. Prior to joining Novartis, Jerry was Executive Vice President of SmithKline Beecham responsible for US operations, European operations, Regulatory, and Strategic Marketing. He has been responsible for numerous pharmaceutical product approvals and new product launches, including the launch of four $1 billion products. Jerry was the Founder and Chairman of the Novartis BioVenture Fund from July 2000 until December 2001. In this role he invested approximately $40 million in 14 portfolio companies. Jerry holds a Ph.D. in Pharmacokinetics from the Massachusetts College of Pharmacy. He is a member of the Visiting Committee for Health Sciences and Technology at MIT. He is Chairman of SkyePharma PLC and Human Genome Sciences, Inc., and is Chairman or a Director of several Care Capital portfolio companies.
Follow Argeris Karabelas:
About Apple Tree Partners, Care Capital, Novartis, SmithKline Beecham Pharmaceuticals (SB): Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Michael Ehlers
Chief Scientific Officer and Venture Partner of Apple Tree Partners
Follow Michael Ehlers:
About Apple Tree Partners, Aulos Bioscience, Intergalactic Therapeutics: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Alexander McCampbell
Venture Partner of Apple Tree Partners
Alexander McCampbell is a venture partner at ATP. A highly skilled pharmaceutical scientist specializing in rare and neurodegenerative diseases, Alex worked at Biogen for nine years, most recently as a vice president building and leading a translational team of 25 people in neuromuscular and muscle research. He has advanced eight agents into the clinic with a range of modalities, including antibodies, small molecules, and antisense oligonucleotides, in disease areas including amyotrophic lateral sclerosis, Alzheimer’s disease, and spinal muscular atrophy (SMA). These efforts have resulted to date in one approved drug for SMA (Spinraza™) and multiple drug candidates in proof of concept or pivotal stage trials. Alex has also been integral in multiple business development deals as the scientific point person on strategic collaborations. He has more than 30 publications spanning nearly two decades and multiple patents, and he has participated on scientific advisory boards and NIH study sections. Alex received his PhD in Neuroscience from the University of Pennsylvania and completed his post-doctoral training at Harvard Medical School.
Follow Alexander McCampbell:
About Apple Tree Partners: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Jonathan Young
Venture Partner of Apple Tree Partners
Jonathan Young is President and CEO of Akero Therapeutics, a company he co-founded to advance promising new therapeutics to treat metabolic disease. Jonathan joined Apple Tree Partners as a Venture Partner in 2016 and has more than 15 years of experience in drug development, biotech law, and public policy. Prior to joining ATP, Jonathan served as General Counsel and Vice President of Policy/Advocacy at Braeburn Pharmaceuticals, Inc., an ATP portfolio company. Jonathan held multiple cross-functional leadership roles at Braeburn, including efforts related to US marketing approval for Probuphine (buprenorphine) subdermal implant; licensing and development of the CAM-2038 buprenorphine injection depot product candidates; acquisition and development of the BB-0817 risperidone implant product candidate and the MedLaunch implant platform; and work to increase federal limits on buprenorphine prescribing for the treatment of opioid addiction. Prior to joining Braeburn, Jonathan was Partner and General Counsel of FoxKiser, a Washington, D.C. law firm specializing in regulatory approval and life cycle management for pharmaceutical and biotechnology companies. Jonathan was appointed by President Barack Obama and confirmed by the US Senate to serve as Chairman of the National Council on Disability, an independent federal agency advising the President and Congress on disability policy, and previously coordinated White House disability policy for President Bill Clinton. Jonathan earned a Ph.D. in American history from the University of North Carolina at Chapel Hill and a J.D. from Yale Law School.
Follow Jonathan Young:
About Akero Therapeutics, Apple Tree Partners: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
George Roberts
Venture Partner of OpenView
George Roberts is the Venture Partner at OpenView.
Follow George Roberts:
About OpenView: OpenView is an expansion stage venture firm that helps grow software companies into market leaders.
Ashley Smith
Venture Partner of OpenView
Ashley Smith is a Venture Partner at OpenView. She has built a long career helping early stage startups scale into successful organizations. She was most recently an executive at GitHub (acquired by Microsoft for $7.5 billion in 2018). Prior to that, she was CMO at GitLab, Head of Marketing at Parse (acquired by Facebook 2013), and got her start in go-to-market in the early days of Twilio (IPO 2016). Smith holds a bachelor’s degree in biomedical engineering from [Georgia Institute of Technology](https://www.crunchbase.com/organization/georgia-institute-of-technology-main-campus#/entity). She lives in New York, United States.
Follow Ashley Smith:
About OpenView: OpenView is an expansion stage venture firm that helps grow software companies into market leaders.
Liz Cain
Venture Partner of OpenView
Liz Cain is a Venture Partner at OpenView.
Follow Liz Cain:
About OpenView: OpenView is an expansion stage venture firm that helps grow software companies into market leaders.
Jason Preston
Venture Partner of Alsop Louie Partners
Jason Preston is the co-founder of Dent, which explores the magic and science of visionary leadership and groundbreaking success. Dent aims to translate the success of great leaders in business, politics, or charity into a set of lessons for those who would “put a dent” in the future. As VP of Strategy and Product Development for the Parnassus Group since 2010, Jason has helped create an innovative social hospitality suite called “Tweet House” at Sundance, SXSW, CES, Comic-Con, and elsewhere. In this role, he also sells high-value sponsorships to parties and conferences and makes strategic determinations for event positioning, media relationships, business partnerships, and editorial focus. Jason has spoken at numerous Seattle-area and national conferences, including the Consumer Electronics Show, The Tweet House, and Ignite Seattle. He has also written about social media and emerging technologies in Crosscut.com and Seattle Business Magazine, and has kept a blog since 2001. His specialties are business development, strategic analysis, editorial writing, brand strategy, event production, WordPress, CSS, basic design, social media tools, social media data analysis, project management, Ruby on Rails, and basic Javascript.
Follow Jason Preston:
About Alsop Louie Partners, Dent: Alsop Louie Partners is a risk-oriented technology venture capital firm that offers financial services to early stage companies.
Sanjay Aggarwal
Venture Partner of F-Prime Capital
Sanjay Aggarwal is a Venture Partner focused on enterprise software and financial technology investments. Prior to joining F-Prime Capital, Sanjay was CEO of Unicel Technologies, an India-focused mobile CRM company. During his tenure with Unicel, he grew revenues by 6x, leading to a successful sale of the business to mGage India. Earlier in his career, Sanjay worked at Devonshire Investors (the private equity group of Fidelity Investments), McKinsey and Company in their US and India offices, and at Berkeley Process Control (acquired by Moog Inc), where he built advanced machine control systems. Sanjay holds a B.S. in Mechanical Engineering from MIT, an M.S. in Mechanical Engineering from UC Berkeley, and an M.B.A. from the MIT Sloan School of Management.
Follow Sanjay Aggarwal:
About Eight Roads Ventures, F-Prime Capital: F-Prime Capital is a venture capital firm investing in healthcare and technology.
Jay Farber
Venture Partner of F-Prime Capital
Head of Growth at Juniper Square.
Follow Jay Farber:
About F-Prime Capital, Juniper Square: F-Prime Capital is a venture capital firm investing in healthcare and technology.
Richard Moley
Venture Partner of Storm Ventures
Richard Moley is a founding venture partner at Storm Ventures. Richard Moley was born and raised in England where he received a BSEE from Manchester University. He worked as an electrical engineer and software developer for a U.K. computer company and a U.S. company on the East Coast before coming to California in 1966. He earned his BSEE from Stanford University and an MBA from Santa Clara University. Between 1966-1973, he worked at Hewlett-Packard and held various positions in Software Development and Marketing. In 1973, he joined ROLM Corporation to lead their Diversification into the telecommunications business. He held the position of Group Vice President before the company was acquired by IBM in 1984. After staying with IBM for 1 1/2 years, he left to join StrataCom. As Chairman, CEO, and President of StrataCom Inc., he pioneered ATM and Frame Relay technology. StrataCom grew through an IPO in 1992 to a revenue run rate of $380/annum in 1996, when the company was acquired by Cisco Systems. He stayed as a senior VP and Board Member of Cisco before resigning in August 1997 to become a private investor in companies. He currently serves on the board for such companies as Linear Technology, Inc., CMC Industries, Inc., CIDCO Inc., Echelon Inc., Netro Inc., and Nefeour Systems, Inc. He is also on the Board of Trustees for Santa Clara University
Follow Richard Moley:
About Storm Ventures: Storm Ventures is a venture capital firm focused solely on early-stage enterprise investments.
Marissa Lowman
Venture Partner of New Markets Venture Partners
Marissa Lowman is the Venture Partner at New Markets Venture Partners
Follow Marissa Lowman:
About New Markets Venture Partners: New Markets Venture Partners is an early and growth stage venture capital firm.
Vlad Sejnoha
Venture Partner of Glasswing Ventures
As Nuance’s Chief Technology Officer, Vlad Sejnoha oversees Nuance’s research and focuses on core technology and product strategy, with an emphasis on emerging areas including natural language processing and mobile applications. Prior to joining Nuance, Vlad was the Chief Scientist at L&H, and earlier at Kurzweil AI, where he was responsible for creating technology for a number of commercially successful speech recognition products, including large vocabulary continuous speech dictation systems. Vlad has over 20 years’ experience in the field of speech recognition and holds thirteen U.S. patents. He earned a BS and Master’s degree in Electrical Engineering from McGill University.
Follow Vlad Sejnoha:
About Glasswing Ventures: Glasswing Ventures is an early-stage VC firm investing in next gen AI and frontier technology startups enabling the intelligent enterprise.
Scott Munro
Venture Partner of Inovia Capital
Scott P. Munro is a Venture Partner at iNovia Capital. Scott Munro founded Pagemill Partners. Scott Munro was the Chairman and Chief Executive Officer of Savoir Technology Group, Inc. Scott Munro initiated and completed 13 acquisitions in areas of hardware, software and services companies and played an integral part in the formation, financing, development and eventual sale of two Silicon Valley based technology companies. He has had operational responsibility for all areas of both large and small companies and has domain expertise in sales, marketing, strategic planning and software development. Scott Munro has been directly responsible for raising over $100 million in equity and/or convertible debt during his management tenure for the aforementioned companies and has completed M&A transactions valued in excess $250 million. He served as a Member of Advisory Board of Wellfleet Partners Investment Arm and has full time operational and functional expertise. He was responsible for the development of all West Coast operations and spearhead all M & A activities. Scott Munro has served on the Board of Directors and Advisory Boards of numerous Public and Private companies including investment banking and venture capital firms and is well versed in almost all technology areas including semiconductors, enterprise software, wireless, telecom and internet services. In 1999, he was recognized by Computer Reseller News as one of the Top Executives to watch. He holds a Bachelor’s Degree in Business Faculties at Concordia University and also received a Graduate Degree in Accounting at McGill University in Montreal, Canada.
Follow Scott Munro:
About Inovia Capital: Inovia Capital is a full-stack venture firm that invests in tech founders.
James W. Young
Venture Partner of 5AM Ventures
James W. Young, PhD joined 5AM Ventures in 2006 as a Venture Partner. James Young has been involved with Sunesis since 2000, as Chief Executive Officer, Executive Chairman and currently as Chairman. Prior to Sunesis, James Young was Senior Vice President, Research and Development and Group Vice President at ALZA Corporation. Before joining ALZA, James Young was President of the Pharmaceuticals Division of Affymax, N.V., and Senior Vice President and General Manager of the Pharmaceuticals Division at Sepracor. Previously, James Young was Vice President of Research at Zoecon/Sandoz Crop Protection Corporation. James Young served as Executive Chairman and then as a Director of Pearl until its acquisition by AstraZeneca.
Follow James W. Young:
About 5AM Ventures, Incline Therapeutics, Sunesis Pharmaceuticals: 5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Mason Freeman
Venture Partner of 5AM Ventures
Mason Freeman, M.D. joined 5AM Ventures as a Scientific Advisor in 2007 and became a Venture Partner in 2008. He serves as Chief of the Lipid Metabolism Unit and Director of Translational Medicine at Massachusetts General Hospital (MGH), Harvard Medical School. Dr. Freeman currently serves as clinical advisor to Relypsa and previously served as Board Director for Envoy (acquired by Takeda). Trained in internal medicine and endocrinology, Dr. Freeman has spent twenty years studying the trafficking of cholesterol into and out of macrophages. As a post-doctoral research fellow in the Biology Department at MIT he cloned the first macrophage scavenger receptor to be molecularly identified. In 1992 he became Chief of the MGH’s Lipid Metabolism Unit, which he continues to direct as well as the Translational Medicine programs at the MGH Center for Computational and Integrative Biology and the MGH Clinical Research Program. In these roles he oversees a basic science research laboratory devoted to studying lipid trafficking as well as a clinical investigative team developing a novel oral anti-diabetic drug.
Follow Mason Freeman:
About 5AM Ventures, Harvard Medical School, Massachusetts General Hospital: 5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Joseph Victor
Venture Partner of 5AM Ventures
Joe Victor joined 5AM Ventures in 2016 as a Venture Partner. Prior to his joining, Mr. Victor served as CEO of Startide Sciences, a 5AM Ventures portfolio company chartered to identify and develop innovative technologies in the Life Sciences research tools markets. Prior to Startide, Mr. Victor served as CEO of DVS Sciences (acquired by Fluidigm Inc.), and Applied Precision Inc (acquired by GE Healthcare). He currently serves as Executive Chairman on the boards of Biodesy, Precision Nanosystems and Purigen Biosystems as well as on the Boards of Glencoe Software, and RareCyte. Mr. Victor also serves as an advisory board member to the Harvard Program in Therapeutic Science and the UC Davis Ecosystem for Biophotonics Innovation. Mr. Victor has also held various executive management and technical positions in the high technology, aviation, and energy markets. Mr. Victor holds an MBA from UCLA and MS and BS degrees in engineering from the University of Washington. Mr. Victor is based in the Menlo Park, CA office.
Follow Joseph Victor:
About 5AM Ventures, RareCyte: 5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Jon Beizer
Venture Partner of Western Technology Investment
Follow Jon Beizer:
About Western Technology Investment: Western Technology Investment is a venture capital firm that specializes in offering acquisition financing to revenue generating firms.
Todd Ruppert
Venture Partner of Greenspring Associates
Follow Todd Ruppert:
About Greenspring Associates: Greenspring Associates is a platform focused on fund, direct, and secondary investments within the venture capital asset class.
Deric Emry
Venture Partner of Greenspring Associates
Follow Deric Emry:
About Greenspring Associates, TIGER 21: Greenspring Associates is a platform focused on fund, direct, and secondary investments within the venture capital asset class.